BBC

Virtus LifeSci Biotech Clinical Trials ETF
*Unless otherwise stated, data provided by FactSet.

BBC Fund Description

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

BBC Factset Analytics Insight

BBC charges a stiff fee for focused exposure to biotech companies with lead drugs still in various phases of clinical trials. Given the low historical success rates in clinical trials, the fund is a high-risk and high-reward bet on a small subset of biotech companies. As such, if you're looking for broad biotech exposure, you won't find it in BBC, which carries an elevated beta and ends up with a basket for primarily small- and micro-cap stocks. That micro-heavy basket means that larger traders might face some obstacles to efficient block execution. Retail traders should likewise handle with care, as volume is weak and spreads can be sizeable. BBC has attracted middling investor interest, but closure risk cannot be dismissed.

BBC MSCI ESG Analytics Insight

Virtus LifeSci Biotech Clinical Trials ETF has an MSCI ESG Fund Rating of B based on a score of 2.80 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Virtus LifeSci Biotech Clinical Trials ETF ranks in the 7th percentile within its peer group and in the 11st percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

BBC Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 12/03/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BBC 18.69% 25.89% 40.30% 15.99% 19.16% -- --
BBC (NAV) 18.53% 25.87% 39.40% 15.46% 19.13% -- --
Thomson Reuters US Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BBC Summary Data

Virtus
12/16/14
Open-Ended Fund
0.79%
$28.65M
$131.64K
0.22%

BBC Portfolio Data

$1.70B
-5.46
4.55
1.24%
N/A
96

BBC Index Data

Equal
Proprietary
Thomson Reuters US Biotechnology & Medical Research

BBC Portfolio Management

0.79%
--
--
--

BBC Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

BBC Fund Structure

Open-Ended Fund
No
Yes
No Policy
N/A
N/A
High
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

BBC Factset Analytics Block Liquidity

As of 12/04/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBC. BBC is rated a 4 out of 5.

BBC Tradability

4,794
$131.64K
2,972
$78.45K
0.22%
$0.06
-0.16%
0.33% / -0.98%
None
100.00%
50,000
0.06
0.03%
0.35%
0
$32.60
4

BBC Sector/Industry Breakdown


BBC
Segment Benchmark
65.64%
55.52%
22.35%
42.23%
5.83%
--
2.81%
--
1.21%
--
1.20%
2.25%
0.96%
--

BBC Countries


BBC
Segment Benchmark
97.37%
100.00%
1.68%
--
0.95%
--

BBC Regions


BBC
Segment Benchmark
97.37%
100.00%
1.68%
--
0.95%
--

BBC Economic Development


BBC
Segment Benchmark
100.00%
100.00%

BBC Performance Statistics

0.80
1.22
1.18
1.33
0.90%
Thomson Reuters US Biotechnology & Medical Research

BBC MSCI ESG Ratings

2.80 / 10
11.39
6.64
--
2.03%
31.33

BBC Benchmark Comparison Holdings

96
148
69
19.34%

BBC Benchmark Comparison Summary


BBC
Segment Benchmark
96
148
$1.70B
$27.13B
-5.46
-54.52
4.55
5.04
0.00%
0.68%
Low
High

BBC Benchmark Comparison Market Cap Size


BBC
Segment Benchmark
0.00%
48.07%
19.50%
30.74%
51.50%
18.39%
29.01%
2.80%